You are here:
View which countries have been approved for each type of Gavi support as of 3 March 2015
Since its launch in 2000, Gavi has helped developing countries to prevent 7 million future deaths from hepatitis B, Haemophilus influenzae type b (Hib), measles, meningitis A, pneumococcal disease, rotavirus diarrhoea and yellow fever.
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2015
modal window here